FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Baltimore plays a losing economic development hand

Tools

Economic development officials in Baltimore are fretting that they're one step behind the pace being set in Montgomery County, where low-cost lab space along with offers of small loans and grants have been luring away emerging drug developers. In the case of Amulet Pharmaceuticals, a spinoff of Johns Hopkins, a $25,000 loan and some free PR proved too much to ignore.

It's a big issue for Baltimore, which has two new bioparks to fill. One particularly thorny issue, according to the Baltimore Business Journal, is getting the city of Baltimore to work as a team with the county. Another key will be in coming up with competitive lease rates for developers in need of lab space.

- read the article in the Baltimore Business Journal

Related Article:
Top Five Regions Targeting Biotech Companies - 2008

More stories about Baltimore   Economic development   Maryland   Amulet Pharmaceuticals   pharmaceuticals  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.